Trimethoprim (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Trimethoprim drug offered from Actavis Pharma, Inc.. This Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Trimethoprim |
SUBSTANCE NAME: | TRIMETHOPRIM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-04-04 |
END MARKETING DATE: | 0000-00-00 |
Trimethoprim HUMAN PRESCRIPTION DRUG Details:
Item Description | Trimethoprim from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2010-04-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-5571_0510dff2-f392-4fb0-a6c6-f07f6d7716a7 |
PRODUCT NDC: | 0591-5571 |
APPLICATION NUMBER: | ANDA070049 |
Other TRIMETHOPRIM Pharmaceutical Manufacturers / Labelers: